However, none of the studies conducted on NAFLD patients have investigated insulin levels, homeostasis model assessment (HOMA-IR), homeostasis model assessment of beta-cell function (HOMA-β), quantitative insulin sensitivity check (QUICKi) index, atherogenic index of plasma (AIP), or blood pressure. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.